Nitrolingual and Panic attack - a phase IV clinical study of FDA data

Summary:

Panic attack is reported as a side effect among people who take Nitrolingual (nitroglycerin), especially for people who are female, 60+ old, also take Lortab, and have High blood pressure.

The phase IV clinical study analyzes which people have Panic attack when taking Nitrolingual. It is created by eHealthMe based on reports of 2,751 people who have side effects when taking Nitrolingual from the FDA, and is updated regularly.

What is Nitrolingual?

Nitrolingual has active ingredients of nitroglycerin. eHealthMe is studying from 2,777 Nitrolingual users. Check the latest studies of Nitrolingual.

What is Panic attack?

Panic attack is found to be associated with 2,261 drugs and 2,082 conditions by eHealthMe. Check the latest studies of Panic attack.

On Jun, 27, 2026

2,751 people reported to have side effects when taking Nitrolingual.
Among them, 11 people (0.4%) have Panic attack.

Among these 11 people:

What is the gender of people who have Panic attack when taking Nitrolingual? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Panic attack when taking Nitrolingual? *

What are other drugs people take besides Nitrolingual? *

What are other side effects people have besides Panic attack? *

Stress And Anxiety: 6 people, 54.55%
Muscle Spasms (muscle contraction): 5 people, 45.45%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 36.36%
Arterial Disorder: 4 people, 36.36%
Asthma: 4 people, 36.36%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 36.36%
Joint Pain: 4 people, 36.36%
Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 36.36%
Dyspnea (difficult or laboured breathing): 4 people, 36.36%
Cardiac Disorder: 4 people, 36.36%

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 45.45%
Joint Pain: 4 people, 36.36%
Asthma: 3 people, 27.27%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 27.27%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 27.27%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 27.27%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
Depression: 2 people, 18.18%
Chest Pain: 2 people, 18.18%
Muscle Spasms (muscle contraction): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrolingual and have Panic attack?

- Check whether Panic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nitrolingual:

Nitrolingual (2,777 reports)

Panic attack treatments and more:

Panic attack (65,704 reports)

Browse all side effects of Nitrolingual:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attack:

Panic attack (2,261 drugs)

Browse all the conditions that are associated with Panic attack:

Panic attack (2,082 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin (the active ingredients of Nitrolingual) and Nitrolingual (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.